STOCK TITAN

Marpai Inc - MRAI STOCK NEWS

Welcome to our dedicated news page for Marpai (Ticker: MRAI), a resource for investors and traders seeking the latest updates and insights on Marpai.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Marpai's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Marpai's position in the market.

Rhea-AI Summary
Marpai, Inc. (Nasdaq: MRAI) has announced two key financing agreements. The company executed an amendment with AXA S.A. delaying payment obligations and securing $1.7 million in revenue-based financing from Libertas Funding, LLC. The amendment with AXA extends payment terms, reduces the remaining payment in 2024 to $473,688, and delays further payments to 2025. AXA has also agreed to certain 'Reduction Criteria' that could potentially reduce the overall payment obligation by $3 million. Marpai also received $1.7 million in revenue-based financing from Libertas, which the company plans to use for short-term working capital needs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.29%
Tags
none
-
News
Rhea-AI Summary
Marpai, Inc. (Nasdaq: MRAI) appoints John Powers as President, an accomplished healthcare benefits executive with over 30 years' experience. Powers brings deep operations knowledge and an extensive industry network, focusing on client savings and high growth. The company aims for rapid efficiencies in operations and achieving a high growth, cash flow positive Company with a strong track record of innovation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.55%
Tags
management
-
Rhea-AI Summary
Marpai, Inc. (Nasdaq: MRAI) announced the addition of two new independent directors to its Board of Directors, Jennifer Calabrese and Robert Pons, as part of the Company's transformation plan and commitment to strong corporate governance and shareholder value creation. The Board will implement a strategic plan to enhance the Company's performance and drive shareholder value creation, positioning Marpai for near- and long-term success.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.18%
Tags
management
Rhea-AI Summary
Marpai, Inc. (Nasdaq: MRAI) has announced that it has regained compliance with Nasdaq's minimum bid price requirement, closing the matter.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.45%
Tags
none
-
Rhea-AI Summary
Marpai, Inc. (Nasdaq: MRAI) has requested a hearing before the Nasdaq Listing Qualifications Panel to appeal the determination by the Listing Qualifications Department of The Nasdaq Stock Market and request a further extension of time to regain compliance with Nasdaq Listing 5550(b)(2). The requested appeal stays any delisting or suspension action pending the issuance of a final decision by the Panel, which has broad discretionary public interest authority. The Panel can grant the Company up to an additional 180 calendar days to regain compliance, but there is no guarantee that the Panel will grant an extension of the compliance period.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Marpai, Inc. (Marpai) (Nasdaq: MRAI) to host Investors Webcast on November 29, 2023, to discuss recent management changes, withdrawal of S-1 Registration, current initiatives, and strategic vision.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.96%
Tags
conferences
Rhea-AI Summary
Marpai, Inc. (Nasdaq: MRAI) reported a 77% increase in total revenue for the third quarter of 2023, reaching $8.7 million, driven by the acquisition of Maestro Health. However, the company experienced an operating loss of $7.0 million and a net loss of $7.3 million during the same period. The withdrawal of the Form S-1 Registration Statement and the suspension of financial guidance for 2023 due to adverse market conditions were also highlighted.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
-
Rhea-AI Summary
Marpai, Inc. announces Damien Lamendola as new CEO and Steve Johnson as CFO. Mike Dendy joins the board. Lamendola is the largest shareholder and a healthcare industry entrepreneur. Marpai aims to create value and reduce healthcare costs through its services.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.67%
Tags
none
-
Rhea-AI Summary
Marpai, Inc. (MRAI) Reports Second Quarter 2023 Financial Results, Net Revenue Increases by 3.8%, Operating Loss Improves, and Net Loss Decreases. The company also disclosed a public offering of 1,850,000 shares of common stock at a public offering price of $4.00 per share, for gross proceeds of $7.4 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.18%
Tags
earnings
Rhea-AI Summary
Marpai, Inc. (Nasdaq: MRAI) to host conference call and webcast on August 3 to discuss deep learning technology in self-funded health insurance market
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
conferences earnings
Marpai Inc

Nasdaq:MRAI

MRAI Rankings

MRAI Stock Data

16.02M
3.92M
65.61%
3.03%
1.65%
Insurance Agencies and Brokerages
Finance and Insurance
Link
United States
New York

About MRAI

marpai health is working at the intersection of healthcare and deep learning, the most advanced form of artificial intelligence. our mission is to predict and prevent costly events in healthcare for the benefit of patients, providers and payors.